Keyphrases
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
100%
HIV Patients
56%
Older Patients
42%
Serum Amyloid A
34%
Highly Active Antiretroviral Therapy (HAART)
27%
C-reactive Protein
26%
Inflammation
26%
AIDS/HIV
23%
Antiretroviral Therapy
22%
Lipodystrophy
20%
Randomized Controlled Trial
19%
Infected Patients
19%
Growth Hormone Treatment
18%
Hospitalization
18%
TREM-1
17%
Cardiovascular Disease
17%
Recombinant Human Growth Hormone (r-hGH)
16%
Denmark
15%
Acutely Ill Patients
15%
Grip Strength
15%
Medicine and Dentistry
Urokinase Receptor
74%
Human immunodeficiency virus
55%
Biological Marker
34%
Highly Active Antiretroviral Therapy
24%
Antiretroviral Therapy
24%
Lipodystrophy
22%
Population
20%
Randomized Controlled Trial
19%
C Reactive Protein
19%